K-numberK260903
Device nameHot Pink Pad Warming System
ApplicantXodus Medical, Inc.
Product codeDWJ
Device classClass II
Decision dateApr 16, 2026
DecisionSubstantially Equivalent
Regulation870.5900
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Hot Pink Pad Warming System is a non-sterile, electrically conductive patient warming device with adjustable temperature control (36.0°C to 40.0°C in 0.5°C increments) designed to assist in patient temperature management and prevent inadvertent hypothermia during surgical procedures. It consists of a reusable controller with display panel, a reusable signal cable, and a single-use foam warming pad, intended for use in hospitals and surgery centers for adult and pediatric patients (excluding neonates).

Technological characteristics

The subject device uses resistive conductive heating via a single-use foam pad (versus the predicate's reusable fabric-covered pad), has one controller output (versus the predicate's two outputs), and operates on mains power only (versus the predicate's mains with optional battery). Both devices feature multiple integrated temperature sensors, visual/audible alarms, automatic shutoff with overtemperature protection, setpoint control via display panel, and universal control unit mounting.

Test standards cited

IEC 60601-1, IEC 60601-1-6, IEC 60601-1-8, IEC 60601-2-35 (safety); IEC 60601-1-2 (EMC); IEC 62304 (software verification and validation); IEC 60601-1-6 and IEC 62366-1 (human factors validation); cleaning and disinfection validation testing per reprocessing requirements.

Substantial equivalence argument

Both devices are non-invasive patient warming systems with identical intended use, use environment, and patient population (adult/pediatric, excluding neonatal). They share the same regulatory classification (Class II, 21 CFR 870.5900, product code DWJ), heating mechanism, temperature sensor implementation, and safety features. Differences in applied part material (single-use versus reusable) and controller outputs represent acceptable variations mitigated by risk analysis and safety testing, with the single-use pad actually presenting lower cross-contamination risk.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →